-
Common kitchen staple may sharpen your brain, and it only takes 2 tablespoons
A Spanish study of 42 healthy adults found that consuming approximately two tablespoons of tomato paste daily for three months resulted in modest improvements in concentration, processing speed and memory compared to a diet low in lycopene, the red antioxidant found in tomatoes. The findings are preliminary and the researchers emphasise that larger studies are…
-
The worst cities in America to be a single mother revealed… and they’re in deep blue states
A study has ranked US cities according to the financial and quality-of-life conditions faced by single mothers, including housing, childcare, safety, healthcare, employment and education. California cities dominated the bottom of the ranking, highlighting the difficulties caused by high living costs, although the article notes that both Democratic and Republican-leaning states appeared among the best…
-
Trump concludes Xi visit as US backs Musk against EU fine
President Trump rounds off the Chinese leader’s state visit with a National Archives tour. The US intervention supports Elon Musk’s legal challenge against a €120m European Union fine on platform X.
-
Paramount To Move Its Class B Shares From Nasdaq To New York Stock Exchange In Early October
Paramount has announced plans to move the listing of its Class B shares from the Nasdaq to the New York Stock Exchange in early October, with trading set to cease on the Nasdaq on 5 October and commence on the NYSE the following day. The company’s board has authorised the stock transfer, though the timing…
-
Valen creator drives ‘Golden Spike’ to connect new languages with Rust
Evan Ovadia, a Mojo core contributor and former Google engineer, has developed an experimental method to pass generic data types and functions between Rust and other programming languages, bypassing the longstanding limitations of the C ABI (application binary interface). Ovadia created this solution whilst developing Valen, his own programming language envisioned as a faster, more…
-
Never smoked a cigarette? You could still be at higher risk for lung cancer
A rare genetic mutation in the EGFR T790M gene dramatically increases the risk of developing lung cancer, even in people who have never smoked, according to a new study published in Science. Researchers from Dana-Farber Cancer Institute and 23andMe analysed data from over 3.3 million people, finding that carriers of the mutation face approximately 62…
-
Zelensky says Russia has widened attacks to hit Ukraine’s data centres
Russia has expanded its military campaign to directly target Ukraine’s data centres and internet infrastructure, according to President Zelensky, in a shift aimed at disrupting civilian life rather than military targets. A Russian drone strike on a business centre in Kyiv on Friday killed four people and damaged a data centre, whilst a separate attack…
-
For months, OpenAI’s agent swarms have been attacking online databases to find obscure facts
Researchers say OpenAI agent swarms have spent months trying to retrieve obscure facts through poorly secured online services, sometimes attempting to access protected databases. The findings raise questions about whether OpenAI knew its agents were probing secure systems and whether safeguards were adequate. Transluce identified activity involving Data USA, the University of New Mexico digital…
-
Essex study finds restaurant complaints cross age and gender lines
A study by the University of Essex suggests that restaurant complaints are not strongly linked to age, gender or income, challenging the stereotype of the middle-aged female “Karen”. Researchers found that diners were more likely to complain when eating out for a special occasion, when problems had occurred before their visit, or when they had…
-
Popular weight-loss drugs may play surprising role in cancer outcomes
Researchers are investigating whether GLP-1 medicines used for weight loss and diabetes could affect cancer risk and outcomes, because obesity is a major risk factor for many cancers. Early studies suggest the drugs may lower cancer risk, improve survival and reduce recurrence, but experts stress that the evidence is mixed and does not yet establish…